ADA: GLP-1 Receptor Agonists May Help Reduce Food Cravings

Share this content:
ADA: GLP-1 Receptor Agonists May Help Reduce Food Cravings
ADA: GLP-1 Receptor Agonists May Help Reduce Food Cravings

(HealthDay News) -- GLP-1 receptor agonists may help reduce cravings and increase satisfaction while eating, according to research scheduled to be presented Tuesday at the annual meeting of the American Diabetes Association, held from June 5 to 9 in Boston.

Liselotte van Bloemendaal, M.D., a Ph.D. student at the Diabetes Center, VU University Medical Center in Amsterdam, and colleagues looked specifically at the injectable GLP-1 receptor agonist exenatide (Bydureon, Byetta). "Using functional magnetic resonance imaging, we looked at the reward centers in the brains of obese individuals with and without type 2 diabetes and measured the response to the anticipation of and drinking of chocolate milk while being given GLP-1 receptor agonist intravenously versus placebo," van Bloemendaal said in an American Diabetes Association news release.

"We found that GLP-1 receptor activation decreased anticipatory food reward, which may reduce cravings, and increased the feeling of food reward during consumption, which may reduce overeating," van Bloemendaal added. The findings may lead to new treatments for obesity, she said.

One avenue that merits further investigation, according to Van Bloemendaal, is whether addition of a second hormone, such as glucagon, could increase weight loss. Van Bloemendaal also wants to determine whether these therapies can reduce cravings for drugs, alcohol, and nicotine.

Press Release
More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures

FDA OKs Doptelet for Liver Dz Patients Undergoing ...

Doptelet reduces the need for platelet transfusion or any rescue therapy on day of procedure

Slower Decline in Lung Function With Anthocyanin Intake

Slower Decline in Lung Function With Anthocyanin Intake

Slower annual rates of decline in FEV1 and FVC for those in highest quartile of anthocyanin intake

Bioengineering Feasible for Airway Reconstruction

Bioengineering Feasible for Airway Reconstruction

Bioengineered tracheal and bronchial reconstruction reported using stented aortic matrices

is free, fast, and customized just for you!

Already a member?

Sign In Now »